Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a small internal update to the page; the study details remain the same.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page content was published.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page. This reflects a backend/template maintenance update and does not alter study details shown to users.SummaryDifference0.0%

- Check54 days agoChange DetectedSite revision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded the keyword 'Squamous cell carcinoma of the head and neck' to the page's keyword/MeSH terms.SummaryDifference0.0%

- Check83 days agoChange DetectedUpdated the site revision to v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.